ARTICLE
12 April 2024

Pharmaceutical Companies May Be The First Targets Of The Washington State My Health My Data Act

GT
Greenberg Traurig, LLP

Contributor

Greenberg Traurig, LLP has more than 2750 attorneys in 47 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI “Highly Recommended Law Firm” for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: www.gtlaw.com.
On April 17, 2023, the Washington State Legislature passed the "My Health My Data Act" (WMHMDA or the Act), which took effect for most companies March 31, 2024.
United States Privacy
To print this article, all you need is to be registered or login on Mondaq.com.

On April 17, 2023, the Washington State Legislature passed the "My Health My Data Act" (WMHMDA or the Act), which took effect for most companies March 31, 2024. Unlike other modern state privacy laws that purport to regulate any collection of "personal data," WMHMDA confers privacy protections only upon "consumer health data." This term is defined to include any data that is linked (or linkable) to an individual and that identifies their "past, present, or future physical or mental health status." As the statute is not intended to apply to HIPAA-regulated entities or employers, there is some confusion regarding its scope (i.e., which companies may be collecting consumer health data) as well as its requirements. Specifically, the Act refers to data that might "identify" a consumer seeking a service to improve or learn about a consumer's mental or physical health as an example of consumer health data. As a result, organizations that traditionally do not consider themselves to be collecting health data, such as grocery stores, newspapers, dietary supplements providers, and even fitness clubs, are uncertain whether the Act may be interpreted to apply to them to the extent that someone seeks out such companies either for information about health or to improve their health.

While courts have not yet been presented with a case under the statute, and the Office of the Washington Attorney General has provided little guidance, plaintiff law firms have already begun seeking individuals who had visited pharmaceutical company websites as well as other medical related providers (e.g., testing companies) to serve as plaintiffs in litigation. While it remains unclear what substantive provision within the statute the law firms will allege was violated, the firms have signaled that pharmaceutical companies may be the first group of targets under the Act. As a result, pharmaceutical companies may want to ensure they are in full compliance with the Act.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More